Literature DB >> 5118126

Metabolism of harmaline in rats.

B T Ho, V Estevez, G E Fritchie, L W Tansey, J Idänpään-Heikkilä, W M McIsaac.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5118126     DOI： 10.1016/0006-2952(71)90363-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  8 in total

1.  Monoclonal antibody to 2-amino-3-methylimidazo(4,5-f)quinoline, a dietary carcinogen.

Authors:  H Yanagisawa; T Tachikawa; S Shin; O Wada
Journal:  Appl Biochem Biotechnol       Date:  1990-01       Impact factor: 2.926

2.  PHARMACOKINETICS In the rat of the hallucinogenic alkaloids harmine and harmaline.

Authors:  G Zetler; G Back; H Iven
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

3.  Harmaline and harmalol inhibit the carcinogen-activating enzyme CYP1A1 via transcriptional and posttranslational mechanisms.

Authors:  Mohamed A M El Gendy; Anatoly A Soshilov; Michael S Denison; Ayman O S El-Kadi
Journal:  Food Chem Toxicol       Date:  2011-10-21       Impact factor: 6.023

4.  Effects of CYP2D6 status on harmaline metabolism, pharmacokinetics and pharmacodynamics, and a pharmacogenetics-based pharmacokinetic model.

Authors:  Chao Wu; Xi-Ling Jiang; Hong-Wu Shen; Ai-Ming Yu
Journal:  Biochem Pharmacol       Date:  2009-05-13       Impact factor: 5.858

5.  Pharmacokinetics of tetrahydronorharmane (tetrahydro-beta-carboline) in rats.

Authors:  B Greiner; C Fähndrich; S Strauss; H Rommelspacher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-03       Impact factor: 3.000

6.  2-Mercaptoacetate administration depresses the beta-oxidation pathway through an inhibition of long-chain acyl-CoA dehydrogenase activity.

Authors:  F Bauché; D Sabourault; Y Giudicelli; J Nordmann; R Nordmann
Journal:  Biochem J       Date:  1981-06-15       Impact factor: 3.857

7.  Effects of 2-mercaptoacetate in isolated liver mitochondria in vitro. Competitive inhibition of 3-hydroxybutyrate dehydrogenase and depression of the beta-oxidation pathway.

Authors:  F Bauché; D Sabourault; Y Giudicelli; J Nordmann; R Nordmann
Journal:  Biochem J       Date:  1982-07-15       Impact factor: 3.857

8.  Copper amine oxidases catalyze the oxidative deamination and hydrolysis of cyclic imines.

Authors:  Toshiki Nagakubo; Takuto Kumano; Takehiro Ohta; Yoshiteru Hashimoto; Michihiko Kobayashi
Journal:  Nat Commun       Date:  2019-01-24       Impact factor: 14.919
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.